Skip to content
Screener

PP&E (Net) at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$6.08B-10.8%
Stryker logo
StrykerSYK
$3.96B+6.9%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
$458.88K-77.7%
Axogen logo
AxogenAXGN
$82.34M-0.1%
Globus Medical logo
Globus MedicalGMED
$533.53M-9.2%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$2.91M+33.5%

Segments

By geography

See full
Europe$56.82M+8.5%
Asia Pacific$33.99M+20.3%
Rest of the World$1.25M-3.2%

Other financials

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total debt$2.0B+3.2%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation

See full
Market cap$1.33B+38.0%
Enterprise value$3.08B+16.2%
P/S0.8×+0.2×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-0.7%
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000917520-26-000058
Line itemJune 30, 2026December 31, 2025
Prepaid expenses104,34496,089
Other current assets53,86128,130
Total current assets1,191,4821,159,544
Property, plant and equipment, net446,202444,335
Right of use asset - operating leases137,085140,568
Intangible assets, net1,075,5421,134,663
Goodwill611,145615,157
Deferred tax assets, net70,44369,854

Item 1. Financial Statements

FAQ

What is Integra LifeSciences's PP&E (net)?
Integra LifeSciences (IART) reported PP&E (net) of $446.2M in Q2 2026.
How has Integra LifeSciences's PP&E (net) changed year-over-year?
Integra LifeSciences's PP&E (net) increased by 2.6% year-over-year, from $434.82M to $446.2M.
What is the long-term trend for Integra LifeSciences's PP&E (net)?
Over 5 years (2020 to 2025), Integra LifeSciences's PP&E (net) has grown at a 9.1% compound annual growth rate (CAGR), from $287.53M to $444.34M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Integra LifeSciences's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude